Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Pediatric Neurology Devices Market Share

ID: MRFR/MED/0122-HCR
115 Pages
Rahul Gotadki
April 2026

Pediatric Neurology Devices Market Size, Application and Growth Analysis By Type (Neurostimulator) By Service & Treatment (Electroencephalogram) Neurological Subspecialties (Stroke) By Age Group (Infants) By End User (Hospitals), By Regions - Industry Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Global Pediatric Neurology Devices Market Infographic
Purchase Options

Market Share

Global Pediatric Neurology Devices Market Share Analysis

The pediatric neurology device market plays a pivotal job in addressing the one-of-a-kind medical care needs of children with neurological conditions. Companies position themselves by creating specialized diagnostic tools custom fitted for pediatric neurology. These tools might incorporate neuroimaging devices, electroencephalography (EEG) systems, and other diagnostic hardware specifically designed for the one-of-a-kind physical and physiological characteristic of pediatric patients. Offering corrective devices for the treatment of pediatric neurological disorders is a strategic move. Companies foster devices such as neuromodulation devices, neurostimulation therapies, and restoration tools designed to address the specific needs of children with conditions like epilepsy, cerebral palsy, and neurodevelopmental disorders. Strategic positioning involves the improvement of assistive technologies for pediatric patients with neurological challenges. This includes devices such as correspondence aids, versatility devices, and versatile technologies to work on the general personal satisfaction for children with neurologic disabilities. Continuous development in child-compliant technologies is a unique strategy for market positioning. This includes integrating features such as smart interfaces, gamification elements, and wearable technologies to make pediatric neurology devices seriously captivating and less scary for youthful patients. Development contributes to worked on understanding consistency and positive medical services experiences for children. Establishing an association with the pediatric medical services local area and patient support groups is an essential part of market positioning. Companies participate in local area outreach, support programs, and backing initiatives to associate with families, understand their needs, and add to the general improvement of pediatric neurology care. To stay at the front of the market, companies effectively screen worldwide pediatric medical care trends. Staying informed about arising technologies, treatment protocols, and developing medical services practices enables companies to adjust their strategies to meet the changing needs of pediatric patients around the world.

Author
Author Profile
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Leave a Comment

FAQs

What is the projected market valuation of the Pediatric Neurology Devices Market by 2035?

<p>The Pediatric Neurology Devices Market is projected to reach a valuation of 4.096 USD Billion by 2035.</p>

What was the market valuation of the Pediatric Neurology Devices Market in 2024?

<p>In 2024, the market valuation of the Pediatric Neurology Devices Market was 2.074 USD Billion.</p>

What is the expected CAGR for the Pediatric Neurology Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Pediatric Neurology Devices Market during the forecast period 2025 - 2035 is 6.38%.</p>

Which companies are considered key players in the Pediatric Neurology Devices Market?

<p>Key players in the Pediatric Neurology Devices Market include Medtronic, Boston Scientific, Abbott Laboratories, and NeuroPace.</p>

What segment of the Pediatric Neurology Devices Market is projected to grow from 0.6 to 1.2 USD Billion by 2035?

<p>The neurosurgery devices segment is projected to grow from 0.6 to 1.2 USD Billion by 2035.</p>

How much is the electroencephalogram segment expected to be valued by 2035?

The electroencephalogram segment is expected to be valued at 0.9 USD Billion by 2035.

What is the projected valuation for the neuro-oncology segment by 2035?

The neuro-oncology segment is projected to reach a valuation of 0.83 USD Billion by 2035.

Which age group is expected to have the highest market valuation in the Pediatric Neurology Devices Market by 2035?

The children age group is expected to have the highest market valuation, projected at 1.662 USD Billion by 2035.

What is the anticipated growth for the hospitals segment in the Pediatric Neurology Devices Market by 2035?

The hospitals segment is anticipated to grow to a valuation of 1.65 USD Billion by 2035.

What are the projected values for the cerebrospinal fluid (CSF) management devices segment by 2035?

The cerebrospinal fluid (CSF) management devices segment is projected to grow from 0.4 to 0.8 USD Billion by 2035.

Market Summary

As per Market Research Future analysis, the Pediatric Neurology Devices Market was estimated at 2.074 USD Billion in 2024. The Pediatric Neurology Devices industry is projected to grow from 2.207 USD Billion in 2025 to 4.096 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 6.38% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Pediatric Neurology Devices Market is experiencing robust growth driven by technological advancements and increasing awareness.

  • North America remains the largest market for pediatric neurology devices, driven by advanced healthcare infrastructure. The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and awareness. Neurosurgery devices dominate the market, while neurostimulators are witnessing the fastest growth due to innovative therapies. Key market drivers include technological advancements and increased awareness, alongside rising incidences of neurological disorders.

Market Size & Forecast

2024 Market Size 2.074 (USD Billion)
2035 Market Size 4.096 (USD Billion)
CAGR (2025 - 2035) 6.38%
Largest Regional Market Share in 2024 Americas

Major Players

Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), NeuroPace (US), Natus Medical Incorporated (US), Stryker Corporation (US), ElectroCore (US), Cerebrotech Medical Systems (US)

Market Trends

The Pediatric Neurology Devices Market is currently experiencing a notable evolution, driven by advancements in technology and an increasing awareness of neurological disorders in children. The integration of innovative devices, such as neurostimulation systems and diagnostic tools, appears to enhance the quality of care provided to pediatric patients. Furthermore, the growing prevalence of conditions like epilepsy and cerebral palsy is likely to propel demand for specialized devices tailored to the unique needs of younger populations. As healthcare providers seek to improve treatment outcomes, the market is poised for substantial growth, reflecting a commitment to addressing the complexities of pediatric neurology. In addition, the Pediatric Neurology Devices Market is witnessing a shift towards more personalized and patient-centric solutions. Manufacturers are increasingly focusing on developing devices that not only cater to clinical requirements but also consider the comfort and usability for children. This trend suggests a broader recognition of the importance of engaging young patients in their treatment processes. Moreover, collaborations between technology firms and healthcare institutions may further stimulate innovation, leading to the introduction of cutting-edge devices that could redefine standards of care in pediatric neurology. Overall, the market is on a trajectory of transformation, with a strong emphasis on enhancing therapeutic options for children with neurological disorders.

Technological Advancements

The Pediatric Neurology Devices Market is significantly influenced by rapid technological advancements. Innovations in neuroimaging, wearable devices, and telemedicine are reshaping how neurological conditions are diagnosed and managed in children. These developments not only improve accuracy but also enhance accessibility to specialized care.

Increased Awareness and Diagnosis

There is a growing awareness regarding pediatric neurological disorders, leading to improved diagnosis rates. As healthcare professionals become more attuned to the signs and symptoms of these conditions, the demand for effective neurology devices is likely to rise. This trend indicates a proactive approach to managing children's neurological health.

Focus on Patient-Centric Solutions

The market is increasingly leaning towards patient-centric solutions that prioritize the comfort and engagement of young patients. Manufacturers are developing devices that are not only effective but also user-friendly for children. This shift reflects a broader understanding of the importance of involving pediatric patients in their treatment.

Global Pediatric Neurology Devices Market Market Drivers

Increased Awareness and Diagnosis

There is a notable increase in awareness regarding pediatric neurological disorders, which is significantly impacting the Pediatric Neurology Devices Market. Parents, educators, and healthcare professionals are becoming more informed about the symptoms and implications of conditions such as epilepsy, cerebral palsy, and autism spectrum disorders. This heightened awareness is leading to earlier diagnosis and intervention, which is crucial for effective treatment. According to recent studies, early diagnosis can improve the quality of life for affected children, thereby driving demand for specialized devices. The market is witnessing a shift towards more comprehensive diagnostic tools that cater to this growing need, indicating a robust growth trajectory in the coming years.

Focus on Patient-Centric Solutions

The Pediatric Neurology Devices Market is increasingly focusing on patient-centric solutions that prioritize the unique needs of children. This shift is evident in the design and functionality of devices, which are now being developed with a child-friendly approach. Manufacturers are investing in research to create devices that are not only effective but also comfortable and engaging for young patients. This trend is likely to enhance adherence to treatment protocols, as children are more likely to cooperate with devices that are designed with their preferences in mind. The market is expected to expand as healthcare providers recognize the importance of patient-centricity in improving treatment outcomes.

Government Initiatives and Funding

Government initiatives and funding aimed at improving pediatric healthcare are playing a pivotal role in the Pediatric Neurology Devices Market. Various governments are recognizing the importance of addressing pediatric neurological disorders and are allocating resources to support research and development in this field. Initiatives that promote awareness, early diagnosis, and access to advanced treatment options are likely to stimulate market growth. Additionally, funding for innovative device development is expected to increase, fostering collaboration between public and private sectors. This supportive environment is anticipated to drive advancements in pediatric neurology devices, ultimately benefiting children with neurological conditions.

Rising Incidence of Neurological Disorders

The rising incidence of neurological disorders among children is a critical driver for the Pediatric Neurology Devices Market. Recent statistics indicate that conditions such as attention deficit hyperactivity disorder (ADHD) and epilepsy are becoming increasingly prevalent. This trend necessitates the development and availability of specialized devices for diagnosis and management. As healthcare systems strive to address this growing burden, there is a corresponding increase in investment in pediatric neurology devices. The market is projected to respond positively to this demand, with an expected growth rate of around 7% annually, reflecting the urgent need for effective solutions in pediatric neurology.

Technological Advancements in Pediatric Neurology Devices

The Pediatric Neurology Devices Market is experiencing a surge in technological advancements that enhance diagnostic and therapeutic capabilities. Innovations such as advanced imaging techniques, neurostimulation devices, and wearable monitoring systems are becoming increasingly prevalent. For instance, the integration of artificial intelligence in diagnostic tools is streamlining the identification of neurological disorders in children. This technological evolution not only improves accuracy but also reduces the time taken for diagnosis. Furthermore, the market is projected to grow at a compound annual growth rate of approximately 8% over the next five years, driven by these advancements. As a result, healthcare providers are more equipped to offer tailored treatments, thereby improving patient outcomes and satisfaction.

Market Segment Insights

By Type: Neurosurgery Devices (Largest) vs. Neurostimulator (Fastest-Growing)

In the Pediatric Neurology Devices Market, the distribution of market share among various types is well-diversified, with neurosurgery devices holding the largest portion. This dominance is attributed to the essential role these devices play in managing complex neurological conditions in pediatric patients. Following closely, neurostimulators represent a growing share, driven by technological advancements that enhance treatment efficacy and patient outcomes.

Neurosurgery Devices (Dominant) vs. Neurostimulator (Emerging)

Neurosurgery devices are characterized by their critical applications in surgical interventions for pediatric neurological disorders, often including a broad range of tools and technologies such as scalpels, clamps, and imaging equipment. Their dominant market position stems from the necessity of surgical management for various conditions, ensuring long-term improvements in quality of life for young patients. In contrast, neurostimulators are emerging as a pivotal segment, gaining traction due to innovations in non-invasive treatment options. They are particularly valuable for conditions like epilepsy and chronic pain, offering effective solutions with reduced risks, thus attracting increasing interest from healthcare providers and patients alike.

By Service & Treatment: Electroencephalogram (Largest) vs. Intrathecal Baclofen Therapy (Fastest-Growing)

The Pediatric Neurology Devices Market is primarily dominated by electroencephalogram (EEG) devices, capturing the largest share due to their critical role in diagnosing various neurological disorders. Following EEG, intrathecal baclofen therapy is emerging with significant advancements, showcasing strong growth trends in usage and acceptance. Neurological evaluations, vagal nerve stimulation, and other treatment methods continue to contribute but hold smaller portions of the market share. With a growing focus on personalized medicine, these treatments are under constant evaluation for efficacy and adoption rates, impacting their overall market positioning. Recent trends in the Pediatric Neurology Devices Market indicate a shift towards innovative treatment options. Intrathecal baclofen therapy, recognized for its effectiveness in managing spasticity, is gaining traction as a fast-growing segment. Additionally, the increasing prevalence of neurological disorders in children is driving demand for advanced diagnostic tools like EEGs. This, coupled with a trend toward patient-centric care, suggests that both established and emerging segment values are likely to witness continued growth as technology evolves and treatment paradigms shift.

Electroencephalogram (Dominant) vs. Intrathecal Baclofen Therapy (Emerging)

Electroencephalogram (EEG) devices serve as the dominant force in the Pediatric Neurology Devices Market, owing to their established reputation in diagnosing conditions like epilepsy and sleep disorders in children. These devices are essential for monitoring brain activity and are pivotal in treatment planning. Meanwhile, Intrathecal baclofen therapy is identified as an emerging solution, designed to provide targeted relief from severe spasticity. Its innovative delivery and growing body of research illustrate promising outcomes for patients. As therapies become more tailored, the recognition of both EEG and intrathecal baclofen therapy underscores a duality in market strengths, highlighting the importance of established protocols alongside pioneering techniques in enhancing pediatric patient care.

By Neurological Subspecialties: Neuro-oncology (Largest) vs. Neuromuscular (Fastest-Growing)

The Pediatric Neurology Devices Market is segmented into various subspecialties, each catering to specific neurological conditions. Among these, neuro-oncology leads as the largest segment, attributed to the high prevalence of <a href="https://www.marketresearchfuture.com/reports/pediatric-brain-tumor-market-3690" target="_blank" title="pediatric brain tumor">pediatric brain tumors</a> and the increasing number of therapeutic interventions. Neuromuscular devices follow closely, addressing conditions like muscular dystrophy and spinal muscular atrophy, reflecting a growing awareness of neuromuscular disorders in children. Growth trends indicate that while neuro-oncology remains dominant, the neuromuscular segment is emerging as the fastest-growing area. This growth is driven by advancements in technology, personalized treatment approaches, and an increasing focus on early diagnosis and intervention. Pediatric neurology practices are evolving, with innovative devices enhancing patient care and treatment outcomes in these subspecialties.

Neuro-oncology (Dominant) vs. Neuromuscular (Emerging)

The neuro-oncology segment is characterized by its focus on devising advanced diagnostic and treatment devices for pediatric brain tumors, which are increasingly being recognized as critical due to their impact on long-term health outcomes in children. This segment includes a range of devices from imaging tools to therapeutic agents designed for targeted therapy. Conversely, the neuromuscular segment, while currently the emerging area, focuses on the development of devices that assist in the management of neuromuscular disorders, such as those that enhance mobility and functionality in children with conditions like muscular dystrophy. The emphasis on early diagnosis and comprehensive care strategies has fueled rapid innovation in this area, leading to a notable increase in device adoption.

By Age Group: Children (Largest) vs. Adolescents (Fastest-Growing)

In the Pediatric Neurology Devices Market, the age group segment is characterized by a varied distribution among neonates, infants, children, and adolescents. Among these, children represent the largest share, driven by the significant prevalence of neurological disorders requiring specialized devices. Infants and neonates, while smaller in market share, are critical segments where specialized devices are increasingly being developed to ensure better health outcomes. Adolescents, on the other hand, have gained momentum as a rapidly growing segment due to rising awareness and tailored neurological interventions being introduced for this age bracket. Growth trends within this segment are influenced by several key factors, including advancements in technology, increased availability of specialized devices, and a growing focus on early diagnosis and intervention. There is a notable push for more pediatric-specific devices tailored to meet the unique anatomical and physiological needs of younger patients. As healthcare systems evolve, the demand for innovative solutions and devices catering to the neurological needs of these age groups continues to rise, particularly for adolescents, which is becoming a focal point for product development and investment in the sector.

Children (Dominant) vs. Adolescents (Emerging)

The comparison between children and adolescents in the Pediatric Neurology Devices Market highlights a significant contrast in their market characteristics. Children emerge as the dominant segment due to their larger patient population and comprehensive range of neurology devices available to them, addressing disorders like epilepsy, cerebral palsy, and developmental delays. These devices have been extensively researched and validated for efficacy. Conversely, the segment of adolescents represents an emerging market, characterized by the recent inspiration for development in specialization and innovation in devices to cater to their complex neurological needs. This demographic is increasingly recognized for its unique challenges, and there is a growing emphasis on custom solutions that provide effective treatment options, promoting better health and growth outcomes.

By End User: Hospitals (Largest) vs. Healthcare Centers (Fastest-Growing)

In the Pediatric Neurology Devices Market, hospitals represent the largest segment, commanding a significant share due to their capacity to provide comprehensive care and a wide range of pediatric neurology services. Healthcare centers, while smaller in size, are rapidly emerging as critical players, particularly in community-based settings where accessibility and affordability of care are paramount. This distribution reflects an increased demand for specialized pediatric services in both urban and rural settings, influencing how these facilities invest in pediatric neurology devices.

Hospitals (Dominant) vs. Neurological Research Centers (Emerging)

Hospitals hold a dominant position in the Pediatric Neurology Devices Market as they offer a centralized hub for advanced diagnostics and treatment options for pediatric neurological conditions. Their extensive infrastructure supports the investment in cutting-edge technology and specialist staff, resulting in a steady demand for various neurological devices. Conversely, neurological research centers are emerging as important contributors to this sector, focusing on innovative research and development of new treatments and technologies. The collaboration between hospitals and these research centers enhances knowledge transfer and fosters the development of breakthrough devices, catering to the evolving needs of pediatric patients.

Get more detailed insights about Pediatric Neurology Device Market Research Report -Forecast till 2035

Regional Insights

North America : Leading Innovation and Demand

North America is the largest market for pediatric neurology devices, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of neurological disorders in children, and significant investments in research and development. Regulatory support from agencies like the FDA further catalyzes innovation and market expansion, ensuring that new devices meet stringent safety and efficacy standards. The United States is the primary contributor to this market, with key players such as Medtronic, Boston Scientific, and Abbott Laboratories leading the charge. The competitive landscape is characterized by continuous technological advancements and strategic partnerships among companies. The presence of established healthcare systems and a focus on pediatric care enhances the market's growth potential, making it a hub for innovation in pediatric neurology devices.

Europe : Emerging Market with Growth Potential

Europe is the second-largest market for pediatric neurology devices, accounting for approximately 30% of the global market share. The region is witnessing growth due to increasing awareness of pediatric neurological disorders, supportive healthcare policies, and a rise in funding for medical research. Regulatory frameworks, such as the European Medicines Agency guidelines, are pivotal in ensuring the safety and effectiveness of new devices, fostering a conducive environment for market growth. Leading countries in this region include Germany, France, and the UK, where healthcare systems are increasingly prioritizing pediatric care. The competitive landscape features both established companies and emerging startups, with a focus on innovative solutions tailored for children. Key players like Natus Medical and Stryker Corporation are actively involved in expanding their product offerings, enhancing the overall market landscape.

Asia-Pacific : Rapid Growth and Development

Asia-Pacific is rapidly emerging as a significant market for pediatric neurology devices, holding approximately 20% of the global market share. The region's growth is fueled by rising healthcare expenditures, increasing awareness of neurological disorders, and a growing population of children. Governments are implementing policies to improve healthcare access, which is further driving demand for advanced medical devices tailored for pediatric care. Countries like China, India, and Japan are at the forefront of this growth, with substantial investments in healthcare infrastructure and technology. The competitive landscape is evolving, with both multinational corporations and local manufacturers vying for market share. Key players are focusing on collaborations and partnerships to enhance their product offerings and expand their reach in this burgeoning market.

Middle East and Africa : Untapped Potential and Challenges

The Middle East and Africa region represents an emerging market for pediatric neurology devices, accounting for approximately 5% of the global market share. The growth in this region is driven by increasing healthcare investments, a rising prevalence of neurological disorders, and a growing awareness of pediatric health issues. However, challenges such as limited healthcare infrastructure and regulatory hurdles can impede market growth, necessitating targeted strategies to overcome these barriers. Countries like South Africa and the UAE are leading the way in healthcare advancements, with a focus on improving pediatric care. The competitive landscape is characterized by a mix of local and international players, with companies exploring opportunities to introduce innovative solutions. As healthcare systems evolve, the demand for specialized pediatric neurology devices is expected to rise, presenting significant opportunities for growth in the region.

Key Players and Competitive Insights

The Pediatric Neurology Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of neurological disorders among children. Key players such as Medtronic (US), Boston Scientific (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Medtronic (US) emphasizes its commitment to developing cutting-edge neuromodulation devices, while Boston Scientific (US) is leveraging its expertise in minimally invasive technologies to expand its product offerings. Abbott Laboratories (US) is strategically positioning itself through acquisitions and collaborations aimed at enhancing its pediatric neurology portfolio, thereby shaping a competitive environment that prioritizes innovation and comprehensive care solutions.

The market structure appears moderately fragmented, with several players vying for market share through localized manufacturing and optimized supply chains. Companies are increasingly localizing their production to reduce costs and improve responsiveness to regional demands. This strategy not only enhances operational efficiency but also allows for tailored solutions that meet specific market needs. The collective influence of these key players fosters a competitive atmosphere where innovation and strategic positioning are paramount.

In August 2025, Medtronic (US) announced the launch of a new pediatric neuromodulation device designed to treat epilepsy in children. This device incorporates advanced algorithms to personalize treatment, reflecting Medtronic's focus on innovation and patient-centric solutions. The introduction of this device is likely to strengthen Medtronic's market position by addressing a critical need in pediatric care, potentially leading to improved patient outcomes and increased market share.

In September 2025, Boston Scientific (US) entered into a partnership with a leading pediatric hospital to develop a specialized training program for healthcare professionals focused on the use of its neurology devices. This initiative underscores Boston Scientific's commitment to enhancing the skill set of practitioners, thereby ensuring optimal device utilization and patient care. Such strategic collaborations may enhance the company's reputation and foster loyalty among healthcare providers, ultimately driving sales growth.

In July 2025, Abbott Laboratories (US) completed the acquisition of a small biotech firm specializing in pediatric neurology diagnostics. This acquisition is indicative of Abbott's strategy to expand its capabilities in the pediatric segment, particularly in diagnostic tools that complement its existing device portfolio. By integrating these new technologies, Abbott is likely to enhance its competitive edge and offer more comprehensive solutions to healthcare providers.

As of October 2025, the Pediatric Neurology Devices Market is witnessing trends such as digitalization, AI integration, and a growing emphasis on sustainability. Companies are increasingly forming strategic alliances to leverage complementary strengths, thereby enhancing their competitive positioning. The shift from price-based competition to a focus on innovation and technology is evident, as firms prioritize reliability in their supply chains and the development of advanced solutions. This evolution suggests that future competitive differentiation will hinge on the ability to innovate and adapt to the changing landscape of pediatric healthcare.

Key Companies in the Global Pediatric Neurology Devices Market include

Industry Developments

Future Outlook

Global Pediatric Neurology Devices Market Future Outlook

The Pediatric Neurology Devices Market is projected to grow at a 6.38% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of neurological disorders, and rising healthcare expenditure.

New opportunities lie in:

  • <p>Development of AI-driven diagnostic tools for early detection of pediatric neurological conditions. Expansion of telehealth services for remote monitoring and consultation. Partnerships with educational institutions for research on innovative pediatric neurology devices.</p>

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

Global Pediatric Neurology Devices Market Type Outlook

  • neurosurgery devices
  • neurostimulator
  • cerebrospinal fluid (CSF) management devices
  • others

Global Pediatric Neurology Devices Market End User Outlook

  • hospitals
  • healthcare centers
  • neurological research centers
  • others

Global Pediatric Neurology Devices Market Age Group Outlook

  • neonates
  • infants
  • children
  • adolescents

Global Pediatric Neurology Devices Market Service & Treatment Outlook

  • electroencephalogram
  • intrathecal baclofen therapy
  • neurological evaluations
  • vagal nerve stimulation
  • others

Global Pediatric Neurology Devices Market Neurological Subspecialties Outlook

  • neuro-oncology
  • neuromuscular
  • neonatal neurology
  • neuro-immunology
  • stroke
  • others

Report Scope

MARKET SIZE 2024 2.074(USD Billion)
MARKET SIZE 2025 2.207(USD Billion)
MARKET SIZE 2035 4.096(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.38% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), NeuroPace (US), Natus Medical Incorporated (US), Stryker Corporation (US), ElectroCore (US), Cerebrotech Medical Systems (US)
Segments Covered Type
Key Market Opportunities Integration of advanced neuroimaging technologies enhances diagnostic capabilities in the Pediatric Neurology Devices Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation in the Pediatric Neurology Devices Market, enhancing treatment options.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Pediatric Neurology Devices Market by 2035?

<p>The Pediatric Neurology Devices Market is projected to reach a valuation of 4.096 USD Billion by 2035.</p>

What was the market valuation of the Pediatric Neurology Devices Market in 2024?

<p>In 2024, the market valuation of the Pediatric Neurology Devices Market was 2.074 USD Billion.</p>

What is the expected CAGR for the Pediatric Neurology Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Pediatric Neurology Devices Market during the forecast period 2025 - 2035 is 6.38%.</p>

Which companies are considered key players in the Pediatric Neurology Devices Market?

<p>Key players in the Pediatric Neurology Devices Market include Medtronic, Boston Scientific, Abbott Laboratories, and NeuroPace.</p>

What segment of the Pediatric Neurology Devices Market is projected to grow from 0.6 to 1.2 USD Billion by 2035?

<p>The neurosurgery devices segment is projected to grow from 0.6 to 1.2 USD Billion by 2035.</p>

How much is the electroencephalogram segment expected to be valued by 2035?

The electroencephalogram segment is expected to be valued at 0.9 USD Billion by 2035.

What is the projected valuation for the neuro-oncology segment by 2035?

The neuro-oncology segment is projected to reach a valuation of 0.83 USD Billion by 2035.

Which age group is expected to have the highest market valuation in the Pediatric Neurology Devices Market by 2035?

The children age group is expected to have the highest market valuation, projected at 1.662 USD Billion by 2035.

What is the anticipated growth for the hospitals segment in the Pediatric Neurology Devices Market by 2035?

The hospitals segment is anticipated to grow to a valuation of 1.65 USD Billion by 2035.

What are the projected values for the cerebrospinal fluid (CSF) management devices segment by 2035?

The cerebrospinal fluid (CSF) management devices segment is projected to grow from 0.4 to 0.8 USD Billion by 2035.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Type (USD Billion)
    2. | | 4.1.1 neurosurgery devices
    3. | | 4.1.2 neurostimulator
    4. | | 4.1.3 cerebrospinal fluid (CSF) management devices
    5. | | 4.1.4 others
    6. | 4.2 Healthcare, BY Service & Treatment (USD Billion)
    7. | | 4.2.1 electroencephalogram
    8. | | 4.2.2 intrathecal baclofen therapy
    9. | | 4.2.3 neurological evaluations
    10. | | 4.2.4 vagal nerve stimulation
    11. | | 4.2.5 others
    12. | 4.3 Healthcare, BY Neurological Subspecialties (USD Billion)
    13. | | 4.3.1 neuro-oncology
    14. | | 4.3.2 neuromuscular
    15. | | 4.3.3 neonatal neurology
    16. | | 4.3.4 neuro-immunology
    17. | | 4.3.5 stroke
    18. | | 4.3.6 others
    19. | 4.4 Healthcare, BY Age Group (USD Billion)
    20. | | 4.4.1 neonates
    21. | | 4.4.2 infants
    22. | | 4.4.3 children
    23. | | 4.4.4 adolescents
    24. | 4.5 Healthcare, BY End User (USD Billion)
    25. | | 4.5.1 hospitals
    26. | | 4.5.2 healthcare centers
    27. | | 4.5.3 neurological research centers
    28. | | 4.5.4 others
    29. | 4.6 Healthcare, BY Region (USD Billion)
    30. | | 4.6.1 North America
    31. | | | 4.6.1.1 US
    32. | | | 4.6.1.2 Canada
    33. | | 4.6.2 Europe
    34. | | | 4.6.2.1 Germany
    35. | | | 4.6.2.2 UK
    36. | | | 4.6.2.3 France
    37. | | | 4.6.2.4 Russia
    38. | | | 4.6.2.5 Italy
    39. | | | 4.6.2.6 Spain
    40. | | | 4.6.2.7 Rest of Europe
    41. | | 4.6.3 APAC
    42. | | | 4.6.3.1 China
    43. | | | 4.6.3.2 India
    44. | | | 4.6.3.3 Japan
    45. | | | 4.6.3.4 South Korea
    46. | | | 4.6.3.5 Malaysia
    47. | | | 4.6.3.6 Thailand
    48. | | | 4.6.3.7 Indonesia
    49. | | | 4.6.3.8 Rest of APAC
    50. | | 4.6.4 South America
    51. | | | 4.6.4.1 Brazil
    52. | | | 4.6.4.2 Mexico
    53. | | | 4.6.4.3 Argentina
    54. | | | 4.6.4.4 Rest of South America
    55. | | 4.6.5 MEA
    56. | | | 4.6.5.1 GCC Countries
    57. | | | 4.6.5.2 South Africa
    58. | | | 4.6.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Medtronic (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Boston Scientific (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Abbott Laboratories (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 NeuroPace (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Natus Medical Incorporated (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Stryker Corporation (US)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 ElectroCore (US)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Cerebrotech Medical Systems (US)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | 5.3 Appendix
    65. | | 5.3.1 References
    66. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY TYPE
    4. | 6.4 US MARKET ANALYSIS BY SERVICE & TREATMENT
    5. | 6.5 US MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    6. | 6.6 US MARKET ANALYSIS BY AGE GROUP
    7. | 6.7 US MARKET ANALYSIS BY END USER
    8. | 6.8 CANADA MARKET ANALYSIS BY TYPE
    9. | 6.9 CANADA MARKET ANALYSIS BY SERVICE & TREATMENT
    10. | 6.10 CANADA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    11. | 6.11 CANADA MARKET ANALYSIS BY AGE GROUP
    12. | 6.12 CANADA MARKET ANALYSIS BY END USER
    13. | 6.13 EUROPE MARKET ANALYSIS
    14. | 6.14 GERMANY MARKET ANALYSIS BY TYPE
    15. | 6.15 GERMANY MARKET ANALYSIS BY SERVICE & TREATMENT
    16. | 6.16 GERMANY MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    17. | 6.17 GERMANY MARKET ANALYSIS BY AGE GROUP
    18. | 6.18 GERMANY MARKET ANALYSIS BY END USER
    19. | 6.19 UK MARKET ANALYSIS BY TYPE
    20. | 6.20 UK MARKET ANALYSIS BY SERVICE & TREATMENT
    21. | 6.21 UK MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    22. | 6.22 UK MARKET ANALYSIS BY AGE GROUP
    23. | 6.23 UK MARKET ANALYSIS BY END USER
    24. | 6.24 FRANCE MARKET ANALYSIS BY TYPE
    25. | 6.25 FRANCE MARKET ANALYSIS BY SERVICE & TREATMENT
    26. | 6.26 FRANCE MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    27. | 6.27 FRANCE MARKET ANALYSIS BY AGE GROUP
    28. | 6.28 FRANCE MARKET ANALYSIS BY END USER
    29. | 6.29 RUSSIA MARKET ANALYSIS BY TYPE
    30. | 6.30 RUSSIA MARKET ANALYSIS BY SERVICE & TREATMENT
    31. | 6.31 RUSSIA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    32. | 6.32 RUSSIA MARKET ANALYSIS BY AGE GROUP
    33. | 6.33 RUSSIA MARKET ANALYSIS BY END USER
    34. | 6.34 ITALY MARKET ANALYSIS BY TYPE
    35. | 6.35 ITALY MARKET ANALYSIS BY SERVICE & TREATMENT
    36. | 6.36 ITALY MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    37. | 6.37 ITALY MARKET ANALYSIS BY AGE GROUP
    38. | 6.38 ITALY MARKET ANALYSIS BY END USER
    39. | 6.39 SPAIN MARKET ANALYSIS BY TYPE
    40. | 6.40 SPAIN MARKET ANALYSIS BY SERVICE & TREATMENT
    41. | 6.41 SPAIN MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    42. | 6.42 SPAIN MARKET ANALYSIS BY AGE GROUP
    43. | 6.43 SPAIN MARKET ANALYSIS BY END USER
    44. | 6.44 REST OF EUROPE MARKET ANALYSIS BY TYPE
    45. | 6.45 REST OF EUROPE MARKET ANALYSIS BY SERVICE & TREATMENT
    46. | 6.46 REST OF EUROPE MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    47. | 6.47 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP
    48. | 6.48 REST OF EUROPE MARKET ANALYSIS BY END USER
    49. | 6.49 APAC MARKET ANALYSIS
    50. | 6.50 CHINA MARKET ANALYSIS BY TYPE
    51. | 6.51 CHINA MARKET ANALYSIS BY SERVICE & TREATMENT
    52. | 6.52 CHINA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    53. | 6.53 CHINA MARKET ANALYSIS BY AGE GROUP
    54. | 6.54 CHINA MARKET ANALYSIS BY END USER
    55. | 6.55 INDIA MARKET ANALYSIS BY TYPE
    56. | 6.56 INDIA MARKET ANALYSIS BY SERVICE & TREATMENT
    57. | 6.57 INDIA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    58. | 6.58 INDIA MARKET ANALYSIS BY AGE GROUP
    59. | 6.59 INDIA MARKET ANALYSIS BY END USER
    60. | 6.60 JAPAN MARKET ANALYSIS BY TYPE
    61. | 6.61 JAPAN MARKET ANALYSIS BY SERVICE & TREATMENT
    62. | 6.62 JAPAN MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    63. | 6.63 JAPAN MARKET ANALYSIS BY AGE GROUP
    64. | 6.64 JAPAN MARKET ANALYSIS BY END USER
    65. | 6.65 SOUTH KOREA MARKET ANALYSIS BY TYPE
    66. | 6.66 SOUTH KOREA MARKET ANALYSIS BY SERVICE & TREATMENT
    67. | 6.67 SOUTH KOREA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    68. | 6.68 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP
    69. | 6.69 SOUTH KOREA MARKET ANALYSIS BY END USER
    70. | 6.70 MALAYSIA MARKET ANALYSIS BY TYPE
    71. | 6.71 MALAYSIA MARKET ANALYSIS BY SERVICE & TREATMENT
    72. | 6.72 MALAYSIA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    73. | 6.73 MALAYSIA MARKET ANALYSIS BY AGE GROUP
    74. | 6.74 MALAYSIA MARKET ANALYSIS BY END USER
    75. | 6.75 THAILAND MARKET ANALYSIS BY TYPE
    76. | 6.76 THAILAND MARKET ANALYSIS BY SERVICE & TREATMENT
    77. | 6.77 THAILAND MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    78. | 6.78 THAILAND MARKET ANALYSIS BY AGE GROUP
    79. | 6.79 THAILAND MARKET ANALYSIS BY END USER
    80. | 6.80 INDONESIA MARKET ANALYSIS BY TYPE
    81. | 6.81 INDONESIA MARKET ANALYSIS BY SERVICE & TREATMENT
    82. | 6.82 INDONESIA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    83. | 6.83 INDONESIA MARKET ANALYSIS BY AGE GROUP
    84. | 6.84 INDONESIA MARKET ANALYSIS BY END USER
    85. | 6.85 REST OF APAC MARKET ANALYSIS BY TYPE
    86. | 6.86 REST OF APAC MARKET ANALYSIS BY SERVICE & TREATMENT
    87. | 6.87 REST OF APAC MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    88. | 6.88 REST OF APAC MARKET ANALYSIS BY AGE GROUP
    89. | 6.89 REST OF APAC MARKET ANALYSIS BY END USER
    90. | 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. | 6.91 BRAZIL MARKET ANALYSIS BY TYPE
    92. | 6.92 BRAZIL MARKET ANALYSIS BY SERVICE & TREATMENT
    93. | 6.93 BRAZIL MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    94. | 6.94 BRAZIL MARKET ANALYSIS BY AGE GROUP
    95. | 6.95 BRAZIL MARKET ANALYSIS BY END USER
    96. | 6.96 MEXICO MARKET ANALYSIS BY TYPE
    97. | 6.97 MEXICO MARKET ANALYSIS BY SERVICE & TREATMENT
    98. | 6.98 MEXICO MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    99. | 6.99 MEXICO MARKET ANALYSIS BY AGE GROUP
    100. | 6.100 MEXICO MARKET ANALYSIS BY END USER
    101. | 6.101 ARGENTINA MARKET ANALYSIS BY TYPE
    102. | 6.102 ARGENTINA MARKET ANALYSIS BY SERVICE & TREATMENT
    103. | 6.103 ARGENTINA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    104. | 6.104 ARGENTINA MARKET ANALYSIS BY AGE GROUP
    105. | 6.105 ARGENTINA MARKET ANALYSIS BY END USER
    106. | 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    107. | 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE & TREATMENT
    108. | 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    109. | 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP
    110. | 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    111. | 6.111 MEA MARKET ANALYSIS
    112. | 6.112 GCC COUNTRIES MARKET ANALYSIS BY TYPE
    113. | 6.113 GCC COUNTRIES MARKET ANALYSIS BY SERVICE & TREATMENT
    114. | 6.114 GCC COUNTRIES MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    115. | 6.115 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP
    116. | 6.116 GCC COUNTRIES MARKET ANALYSIS BY END USER
    117. | 6.117 SOUTH AFRICA MARKET ANALYSIS BY TYPE
    118. | 6.118 SOUTH AFRICA MARKET ANALYSIS BY SERVICE & TREATMENT
    119. | 6.119 SOUTH AFRICA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    120. | 6.120 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP
    121. | 6.121 SOUTH AFRICA MARKET ANALYSIS BY END USER
    122. | 6.122 REST OF MEA MARKET ANALYSIS BY TYPE
    123. | 6.123 REST OF MEA MARKET ANALYSIS BY SERVICE & TREATMENT
    124. | 6.124 REST OF MEA MARKET ANALYSIS BY NEUROLOGICAL SUBSPECIALTIES
    125. | 6.125 REST OF MEA MARKET ANALYSIS BY AGE GROUP
    126. | 6.126 REST OF MEA MARKET ANALYSIS BY END USER
    127. | 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. | 6.128 RESEARCH PROCESS OF MRFR
    129. | 6.129 DRO ANALYSIS OF HEALTHCARE
    130. | 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. | 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. | 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. | 6.133 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    134. | 6.134 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    135. | 6.135 HEALTHCARE, BY SERVICE & TREATMENT, 2024 (% SHARE)
    136. | 6.136 HEALTHCARE, BY SERVICE & TREATMENT, 2024 TO 2035 (USD Billion)
    137. | 6.137 HEALTHCARE, BY NEUROLOGICAL SUBSPECIALTIES, 2024 (% SHARE)
    138. | 6.138 HEALTHCARE, BY NEUROLOGICAL SUBSPECIALTIES, 2024 TO 2035 (USD Billion)
    139. | 6.139 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE)
    140. | 6.140 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion)
    141. | 6.141 HEALTHCARE, BY END USER, 2024 (% SHARE)
    142. | 6.142 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    143. | 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY TYPE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY AGE GROUP, 2025-2035 (USD Billion)
    8. | | 7.2.5 BY END USER, 2025-2035 (USD Billion)
    9. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    10. | | 7.3.1 BY TYPE, 2025-2035 (USD Billion)
    11. | | 7.3.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    12. | | 7.3.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    13. | | 7.3.4 BY AGE GROUP, 2025-2035 (USD Billion)
    14. | | 7.3.5 BY END USER, 2025-2035 (USD Billion)
    15. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.4.1 BY TYPE, 2025-2035 (USD Billion)
    17. | | 7.4.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    18. | | 7.4.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    19. | | 7.4.4 BY AGE GROUP, 2025-2035 (USD Billion)
    20. | | 7.4.5 BY END USER, 2025-2035 (USD Billion)
    21. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    22. | | 7.5.1 BY TYPE, 2025-2035 (USD Billion)
    23. | | 7.5.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    24. | | 7.5.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    25. | | 7.5.4 BY AGE GROUP, 2025-2035 (USD Billion)
    26. | | 7.5.5 BY END USER, 2025-2035 (USD Billion)
    27. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.6.1 BY TYPE, 2025-2035 (USD Billion)
    29. | | 7.6.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    30. | | 7.6.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    31. | | 7.6.4 BY AGE GROUP, 2025-2035 (USD Billion)
    32. | | 7.6.5 BY END USER, 2025-2035 (USD Billion)
    33. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.7.1 BY TYPE, 2025-2035 (USD Billion)
    35. | | 7.7.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    36. | | 7.7.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    37. | | 7.7.4 BY AGE GROUP, 2025-2035 (USD Billion)
    38. | | 7.7.5 BY END USER, 2025-2035 (USD Billion)
    39. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.8.1 BY TYPE, 2025-2035 (USD Billion)
    41. | | 7.8.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    42. | | 7.8.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    43. | | 7.8.4 BY AGE GROUP, 2025-2035 (USD Billion)
    44. | | 7.8.5 BY END USER, 2025-2035 (USD Billion)
    45. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    46. | | 7.9.1 BY TYPE, 2025-2035 (USD Billion)
    47. | | 7.9.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    48. | | 7.9.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    49. | | 7.9.4 BY AGE GROUP, 2025-2035 (USD Billion)
    50. | | 7.9.5 BY END USER, 2025-2035 (USD Billion)
    51. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.10.1 BY TYPE, 2025-2035 (USD Billion)
    53. | | 7.10.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    54. | | 7.10.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    55. | | 7.10.4 BY AGE GROUP, 2025-2035 (USD Billion)
    56. | | 7.10.5 BY END USER, 2025-2035 (USD Billion)
    57. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    58. | | 7.11.1 BY TYPE, 2025-2035 (USD Billion)
    59. | | 7.11.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    60. | | 7.11.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    61. | | 7.11.4 BY AGE GROUP, 2025-2035 (USD Billion)
    62. | | 7.11.5 BY END USER, 2025-2035 (USD Billion)
    63. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.12.1 BY TYPE, 2025-2035 (USD Billion)
    65. | | 7.12.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    66. | | 7.12.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    67. | | 7.12.4 BY AGE GROUP, 2025-2035 (USD Billion)
    68. | | 7.12.5 BY END USER, 2025-2035 (USD Billion)
    69. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    70. | | 7.13.1 BY TYPE, 2025-2035 (USD Billion)
    71. | | 7.13.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    72. | | 7.13.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    73. | | 7.13.4 BY AGE GROUP, 2025-2035 (USD Billion)
    74. | | 7.13.5 BY END USER, 2025-2035 (USD Billion)
    75. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.14.1 BY TYPE, 2025-2035 (USD Billion)
    77. | | 7.14.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    78. | | 7.14.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    79. | | 7.14.4 BY AGE GROUP, 2025-2035 (USD Billion)
    80. | | 7.14.5 BY END USER, 2025-2035 (USD Billion)
    81. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    82. | | 7.15.1 BY TYPE, 2025-2035 (USD Billion)
    83. | | 7.15.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    84. | | 7.15.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    85. | | 7.15.4 BY AGE GROUP, 2025-2035 (USD Billion)
    86. | | 7.15.5 BY END USER, 2025-2035 (USD Billion)
    87. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.16.1 BY TYPE, 2025-2035 (USD Billion)
    89. | | 7.16.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    90. | | 7.16.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    91. | | 7.16.4 BY AGE GROUP, 2025-2035 (USD Billion)
    92. | | 7.16.5 BY END USER, 2025-2035 (USD Billion)
    93. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.17.1 BY TYPE, 2025-2035 (USD Billion)
    95. | | 7.17.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    96. | | 7.17.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    97. | | 7.17.4 BY AGE GROUP, 2025-2035 (USD Billion)
    98. | | 7.17.5 BY END USER, 2025-2035 (USD Billion)
    99. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    100. | | 7.18.1 BY TYPE, 2025-2035 (USD Billion)
    101. | | 7.18.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    102. | | 7.18.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    103. | | 7.18.4 BY AGE GROUP, 2025-2035 (USD Billion)
    104. | | 7.18.5 BY END USER, 2025-2035 (USD Billion)
    105. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    106. | | 7.19.1 BY TYPE, 2025-2035 (USD Billion)
    107. | | 7.19.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    108. | | 7.19.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    109. | | 7.19.4 BY AGE GROUP, 2025-2035 (USD Billion)
    110. | | 7.19.5 BY END USER, 2025-2035 (USD Billion)
    111. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    112. | | 7.20.1 BY TYPE, 2025-2035 (USD Billion)
    113. | | 7.20.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    114. | | 7.20.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    115. | | 7.20.4 BY AGE GROUP, 2025-2035 (USD Billion)
    116. | | 7.20.5 BY END USER, 2025-2035 (USD Billion)
    117. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    118. | | 7.21.1 BY TYPE, 2025-2035 (USD Billion)
    119. | | 7.21.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    120. | | 7.21.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    121. | | 7.21.4 BY AGE GROUP, 2025-2035 (USD Billion)
    122. | | 7.21.5 BY END USER, 2025-2035 (USD Billion)
    123. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.22.1 BY TYPE, 2025-2035 (USD Billion)
    125. | | 7.22.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    126. | | 7.22.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    127. | | 7.22.4 BY AGE GROUP, 2025-2035 (USD Billion)
    128. | | 7.22.5 BY END USER, 2025-2035 (USD Billion)
    129. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    130. | | 7.23.1 BY TYPE, 2025-2035 (USD Billion)
    131. | | 7.23.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    132. | | 7.23.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    133. | | 7.23.4 BY AGE GROUP, 2025-2035 (USD Billion)
    134. | | 7.23.5 BY END USER, 2025-2035 (USD Billion)
    135. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    136. | | 7.24.1 BY TYPE, 2025-2035 (USD Billion)
    137. | | 7.24.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    138. | | 7.24.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    139. | | 7.24.4 BY AGE GROUP, 2025-2035 (USD Billion)
    140. | | 7.24.5 BY END USER, 2025-2035 (USD Billion)
    141. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    142. | | 7.25.1 BY TYPE, 2025-2035 (USD Billion)
    143. | | 7.25.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    144. | | 7.25.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    145. | | 7.25.4 BY AGE GROUP, 2025-2035 (USD Billion)
    146. | | 7.25.5 BY END USER, 2025-2035 (USD Billion)
    147. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    148. | | 7.26.1 BY TYPE, 2025-2035 (USD Billion)
    149. | | 7.26.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    150. | | 7.26.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    151. | | 7.26.4 BY AGE GROUP, 2025-2035 (USD Billion)
    152. | | 7.26.5 BY END USER, 2025-2035 (USD Billion)
    153. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    154. | | 7.27.1 BY TYPE, 2025-2035 (USD Billion)
    155. | | 7.27.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    156. | | 7.27.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    157. | | 7.27.4 BY AGE GROUP, 2025-2035 (USD Billion)
    158. | | 7.27.5 BY END USER, 2025-2035 (USD Billion)
    159. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    160. | | 7.28.1 BY TYPE, 2025-2035 (USD Billion)
    161. | | 7.28.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    162. | | 7.28.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    163. | | 7.28.4 BY AGE GROUP, 2025-2035 (USD Billion)
    164. | | 7.28.5 BY END USER, 2025-2035 (USD Billion)
    165. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    166. | | 7.29.1 BY TYPE, 2025-2035 (USD Billion)
    167. | | 7.29.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    168. | | 7.29.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    169. | | 7.29.4 BY AGE GROUP, 2025-2035 (USD Billion)
    170. | | 7.29.5 BY END USER, 2025-2035 (USD Billion)
    171. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    172. | | 7.30.1 BY TYPE, 2025-2035 (USD Billion)
    173. | | 7.30.2 BY SERVICE & TREATMENT, 2025-2035 (USD Billion)
    174. | | 7.30.3 BY NEUROLOGICAL SUBSPECIALTIES, 2025-2035 (USD Billion)
    175. | | 7.30.4 BY AGE GROUP, 2025-2035 (USD Billion)
    176. | | 7.30.5 BY END USER, 2025-2035 (USD Billion)
    177. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    178. | | 7.31.1
    179. | 7.32 ACQUISITION/PARTNERSHIP
    180. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • neurosurgery devices
  • neurostimulator
  • cerebrospinal fluid (CSF) management devices
  • others

Healthcare By Service & Treatment (USD Billion, 2025-2035)

  • electroencephalogram
  • intrathecal baclofen therapy
  • neurological evaluations
  • vagal nerve stimulation
  • others

Healthcare By Neurological Subspecialties (USD Billion, 2025-2035)

  • neuro-oncology
  • neuromuscular
  • neonatal neurology
  • neuro-immunology
  • stroke
  • others

Healthcare By Age Group (USD Billion, 2025-2035)

  • neonates
  • infants
  • children
  • adolescents

Healthcare By End User (USD Billion, 2025-2035)

  • hospitals
  • healthcare centers
  • neurological research centers
  • others
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions
%>